Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig N Robson

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Nucleic Acids Research|April 23, 2019
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivitiesEvangelia Kounatidou, Sirintra Nakjang, Stuart R C McCracken, et al.
BMC Cancer|January 17, 2015
Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cellsJennifer Munkley, Nicholas P Lafferty, Gabriela Kalna, et al.
Biochemical Society Transactions|May 17, 2008
Regulation of gene expression by the RNA-binding protein Sam68 in cancerPrabhakar Rajan, Luke Gaughan, Caroline Dalgliesh, et al.
Journal of Cell Science|July 1, 2004
CD133, a novel marker for human prostatic epithelial stem cellsGavin D Richardson, Craig N Robson, Shona H Lang, et al.
Scientific Reports|August 28, 2015
The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7Jacqueline Stockley, Elke Markert, Yan Zhou, et al.
Oncotarget|June 5, 2018
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survivalUrszula L McClurg, Mahsa Azizyan, Daniel T Dransfield, et al.
Molecular Cancer Therapeutics|June 3, 2010
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibitionCarolyn Wiltshire, Babloo L Singh, Jacqueline Stockley, et al.
The Prostate|July 3, 2013
Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infectionClaire L Townes, Ased Ali, Naomi Gross, et al.
BJU International|August 18, 2012
Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?Haley L Bennett, Jacqueline Stockley, Janis T Fleming, et al.
Oncotarget|December 10, 2013
A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferationJennifer Munkley, Prabhakar Rajan, Nicholas P Lafferty, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Nucleic Acids Research|April 23, 2019
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivitiesEvangelia Kounatidou, Sirintra Nakjang, Stuart R C McCracken, et al.
BMC Cancer|January 17, 2015
Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cellsJennifer Munkley, Nicholas P Lafferty, Gabriela Kalna, et al.
Biochemical Society Transactions|May 17, 2008
Regulation of gene expression by the RNA-binding protein Sam68 in cancerPrabhakar Rajan, Luke Gaughan, Caroline Dalgliesh, et al.
Journal of Cell Science|July 1, 2004
CD133, a novel marker for human prostatic epithelial stem cellsGavin D Richardson, Craig N Robson, Shona H Lang, et al.
Scientific Reports|August 28, 2015
The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7Jacqueline Stockley, Elke Markert, Yan Zhou, et al.
Oncotarget|June 5, 2018
The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survivalUrszula L McClurg, Mahsa Azizyan, Daniel T Dransfield, et al.
Molecular Cancer Therapeutics|June 3, 2010
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibitionCarolyn Wiltshire, Babloo L Singh, Jacqueline Stockley, et al.
The Prostate|July 3, 2013
Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infectionClaire L Townes, Ased Ali, Naomi Gross, et al.
BJU International|August 18, 2012
Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells?Haley L Bennett, Jacqueline Stockley, Janis T Fleming, et al.
Oncotarget|December 10, 2013
A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferationJennifer Munkley, Prabhakar Rajan, Nicholas P Lafferty, et al.
Pageof 10